Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01482923 · ClinicalTrials.gov registry record
Tobacco Assessment and Intervention With Low-Income Persons Living With HIV-AIDS (PLWHA) in Community-Based AIDS Service Organizations
A clinical trial, sponsored by Memorial Sloan Kettering Cancer Center.
- Completed
- Registry status
- 65
- Enrollment target
NCT01482923: Completed study, sponsored by Memorial Sloan Kettering Cancer Center.
NCT01482923 is a clinical trial that has completed, run by Memorial Sloan Kettering Cancer Center. The registered enrollment target is 65 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01482923 has completed, sponsored by Memorial Sloan Kettering Cancer Center.
- COMPLETED
- Registry status
- 65 participants
- Enrollment target
Study Summary
"A treatment session especially for PLWHA to help them discuss and take action about their smoking may be useful."
Primary Outcome
The study will test whether the percentage of eligible and enrolled study participants who complete the assigned intervention is significantly different from a population of percentages centered at 45%, i.e., the "null population percentage," considered a percentage too low to be compatible with feasibility."
Interventions
- BEHAVIORAL Treatment as usual
- BEHAVIORAL AIR (Aspirations, Inspiration, Respiration)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 65 participants |
| Start Date | 2011-11-22 |
| Est. Completion | 2019-10-21 |
What the finished NCT01482923 record still lists
NCT01482923 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 65 participants, a relatively small participant target.
The record links to 0 conditions, and to 2 interventions - of which Treatment as usual is the first listed.
NCT01482923 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01482923 about?
NCT01482923 is a clinical study titled "Tobacco Assessment and Intervention With Low-Income Persons Living With HIV-AIDS (PLWHA) in Community-Based AIDS Service Organizations". "A treatment session especially for PLWHA to help them discuss and take action about their smoking may be useful."
What is the current status of trial NCT01482923?
This trial is currently completed. The enrollment target is 65 participants. The study started on 2011-11-22. Estimated completion is 2019-10-21.
What interventions are being tested in trial NCT01482923?
The interventions under investigation include: Treatment as usual (BEHAVIORAL), AIR (Aspirations, Inspiration, Respiration) (BEHAVIORAL).
Who is sponsoring clinical trial NCT01482923?
This trial is sponsored by Memorial Sloan Kettering Cancer Center, which has 1,884 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03366116 · 65 participants · Phase 1
5-aza-4'-Thio-2'-Deoxycytidine (Aza-TdC) in People With Advanced Solid Tumors
- NCT03603730 · 65 participants · NA
Vagal Nerve Stimulation for Functional Dyspepsia and Gastroparesis
- NCT03796559 · 65 participants · NA
Magseed Enabled Long-Term Localization of Axillary Lymph Nodes
- NCT03993106 · 65 participants · Phase 2
A Study of sEphB4-HSA in Kaposi Sarcoma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI